Hepatocyte-Specific Expression of Human Lysosome Acid Lipase Corrects Liver Inflammation and Tumor Metastasis in lal<sup>-/-</sup> Mice

Hong Du, Ting Zhao, Xinchun Ding, Cong Yan

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The liver is a major organ for lipid synthesis and metabolism. Deficiency of lysosomal acid lipase (LAL; official name Lipa, encoded by Lipa) in mice (lal<sup>-/-</sup>) results in enlarged liver size due to neutral lipid storage in hepatocytes and Kupffer cells. To test the functional role of LAL in hepatocyte, hepatocyte-specific expression of human LAL (hLAL) in lal<sup>-/-</sup> mice was established by cross-breeding of liver-activated promoter (LAP)-driven tTA transgene and (tetO)<inf>7</inf>-CMV-hLAL transgene with lal<sup>-/-</sup> knockout (KO) (LAP-Tg/KO) triple mice. Hepatocyte-specific expression of hLAL in LAP-Tg/KO triple mice reduced the liver size to the normal level by decreasing lipid storage in both hepatocytes and Kupffer cells. hLAL expression reduced tumor-promoting myeloid-derived suppressive cells in the liver of lal<sup>-/-</sup> mice. As a result, B16 melanoma metastasis to the liver was almost completely blocked. Expression and secretion of multiple tumor-promoting cytokines or chemokines in the liver were also significantly reduced. Because hLAL is a secretory protein, lal<sup>-/-</sup> phenotypes in other compartments (eg, blood, spleen, and lung) also ameliorated, including systemic reduction of myeloid-derived suppressive cells, an increase in CD4<sup>+</sup> and CD8<sup>+</sup> T and B lymphocytes, and reduced B16 melanoma metastasis in the lung. These results support a concept that LAL in hepatocytes is a critical metabolic enzyme in controlling neutral lipid metabolism, liver homeostasis, immune response, and tumor metastasis.

Original languageEnglish
Pages (from-to)2379-2389
Number of pages11
JournalAmerican Journal of Pathology
Volume185
Issue number9
DOIs
StatePublished - Sep 1 2015

Fingerprint

Lysosomes
Lipase
Hepatocytes
Neoplasm Metastasis
Inflammation
Liver
Neoplasms
Experimental Melanomas
Kupffer Cells
Transgenes
Lipid Metabolism
Knockout Mice
Lipids
Lung
Hepatomegaly
Chemokines
Names
Breeding
Homeostasis
B-Lymphocytes

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Hepatocyte-Specific Expression of Human Lysosome Acid Lipase Corrects Liver Inflammation and Tumor Metastasis in lal<sup>-/-</sup> Mice. / Du, Hong; Zhao, Ting; Ding, Xinchun; Yan, Cong.

In: American Journal of Pathology, Vol. 185, No. 9, 01.09.2015, p. 2379-2389.

Research output: Contribution to journalArticle

@article{ba39e3eafc0f4193af3ad7e5f7e52008,
title = "Hepatocyte-Specific Expression of Human Lysosome Acid Lipase Corrects Liver Inflammation and Tumor Metastasis in lal-/- Mice",
abstract = "The liver is a major organ for lipid synthesis and metabolism. Deficiency of lysosomal acid lipase (LAL; official name Lipa, encoded by Lipa) in mice (lal-/-) results in enlarged liver size due to neutral lipid storage in hepatocytes and Kupffer cells. To test the functional role of LAL in hepatocyte, hepatocyte-specific expression of human LAL (hLAL) in lal-/- mice was established by cross-breeding of liver-activated promoter (LAP)-driven tTA transgene and (tetO)7-CMV-hLAL transgene with lal-/- knockout (KO) (LAP-Tg/KO) triple mice. Hepatocyte-specific expression of hLAL in LAP-Tg/KO triple mice reduced the liver size to the normal level by decreasing lipid storage in both hepatocytes and Kupffer cells. hLAL expression reduced tumor-promoting myeloid-derived suppressive cells in the liver of lal-/- mice. As a result, B16 melanoma metastasis to the liver was almost completely blocked. Expression and secretion of multiple tumor-promoting cytokines or chemokines in the liver were also significantly reduced. Because hLAL is a secretory protein, lal-/- phenotypes in other compartments (eg, blood, spleen, and lung) also ameliorated, including systemic reduction of myeloid-derived suppressive cells, an increase in CD4+ and CD8+ T and B lymphocytes, and reduced B16 melanoma metastasis in the lung. These results support a concept that LAL in hepatocytes is a critical metabolic enzyme in controlling neutral lipid metabolism, liver homeostasis, immune response, and tumor metastasis.",
author = "Hong Du and Ting Zhao and Xinchun Ding and Cong Yan",
year = "2015",
month = "9",
day = "1",
doi = "10.1016/j.ajpath.2015.05.021",
language = "English",
volume = "185",
pages = "2379--2389",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Hepatocyte-Specific Expression of Human Lysosome Acid Lipase Corrects Liver Inflammation and Tumor Metastasis in lal-/- Mice

AU - Du, Hong

AU - Zhao, Ting

AU - Ding, Xinchun

AU - Yan, Cong

PY - 2015/9/1

Y1 - 2015/9/1

N2 - The liver is a major organ for lipid synthesis and metabolism. Deficiency of lysosomal acid lipase (LAL; official name Lipa, encoded by Lipa) in mice (lal-/-) results in enlarged liver size due to neutral lipid storage in hepatocytes and Kupffer cells. To test the functional role of LAL in hepatocyte, hepatocyte-specific expression of human LAL (hLAL) in lal-/- mice was established by cross-breeding of liver-activated promoter (LAP)-driven tTA transgene and (tetO)7-CMV-hLAL transgene with lal-/- knockout (KO) (LAP-Tg/KO) triple mice. Hepatocyte-specific expression of hLAL in LAP-Tg/KO triple mice reduced the liver size to the normal level by decreasing lipid storage in both hepatocytes and Kupffer cells. hLAL expression reduced tumor-promoting myeloid-derived suppressive cells in the liver of lal-/- mice. As a result, B16 melanoma metastasis to the liver was almost completely blocked. Expression and secretion of multiple tumor-promoting cytokines or chemokines in the liver were also significantly reduced. Because hLAL is a secretory protein, lal-/- phenotypes in other compartments (eg, blood, spleen, and lung) also ameliorated, including systemic reduction of myeloid-derived suppressive cells, an increase in CD4+ and CD8+ T and B lymphocytes, and reduced B16 melanoma metastasis in the lung. These results support a concept that LAL in hepatocytes is a critical metabolic enzyme in controlling neutral lipid metabolism, liver homeostasis, immune response, and tumor metastasis.

AB - The liver is a major organ for lipid synthesis and metabolism. Deficiency of lysosomal acid lipase (LAL; official name Lipa, encoded by Lipa) in mice (lal-/-) results in enlarged liver size due to neutral lipid storage in hepatocytes and Kupffer cells. To test the functional role of LAL in hepatocyte, hepatocyte-specific expression of human LAL (hLAL) in lal-/- mice was established by cross-breeding of liver-activated promoter (LAP)-driven tTA transgene and (tetO)7-CMV-hLAL transgene with lal-/- knockout (KO) (LAP-Tg/KO) triple mice. Hepatocyte-specific expression of hLAL in LAP-Tg/KO triple mice reduced the liver size to the normal level by decreasing lipid storage in both hepatocytes and Kupffer cells. hLAL expression reduced tumor-promoting myeloid-derived suppressive cells in the liver of lal-/- mice. As a result, B16 melanoma metastasis to the liver was almost completely blocked. Expression and secretion of multiple tumor-promoting cytokines or chemokines in the liver were also significantly reduced. Because hLAL is a secretory protein, lal-/- phenotypes in other compartments (eg, blood, spleen, and lung) also ameliorated, including systemic reduction of myeloid-derived suppressive cells, an increase in CD4+ and CD8+ T and B lymphocytes, and reduced B16 melanoma metastasis in the lung. These results support a concept that LAL in hepatocytes is a critical metabolic enzyme in controlling neutral lipid metabolism, liver homeostasis, immune response, and tumor metastasis.

UR - http://www.scopus.com/inward/record.url?scp=84941126699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941126699&partnerID=8YFLogxK

U2 - 10.1016/j.ajpath.2015.05.021

DO - 10.1016/j.ajpath.2015.05.021

M3 - Article

C2 - 26212911

AN - SCOPUS:84941126699

VL - 185

SP - 2379

EP - 2389

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 9

ER -